Precision BioSciences shareholders approve 3.8M share increase for equity plan; elect directors

PRECISION BIOSCIENCES INC

Shareholders approved amendment to 2019 Incentive Award Plan, increasing share reserve by 3.8M shares (58% for, 42% against).
Amendment to certificate of incorporation approved (17.9M for, 1.4M against) to allow officer exculpation under Delaware law.
Melinda Brown and Geno Germano elected as Class I directors (14.3M and 14.3M votes for respectively).
Ratified Deloitte & Touche as independent auditor for FY2026 (22.2M for, 99k against).
Advisory say-on-pay approved (18.7M for, 613k against).

item 5.02 item 5.03 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-26-038220
form_type: 8-K
ticker: DTIL
cik: 0001357874
company_name: PRECISION BIOSCIENCES INC
filed_at: 2026-05-26T21:20:29+00:00
discovered_at: 2026-05-26T21:22:00.190159+00:00
generated_at: 2026-05-26T21:22:48.202218+00:00
sec_items: ["5.02", "5.03", "5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-26-038220
json_url: https://secwatch.observer/filing/0001628280-26-038220.json
markdown_url: https://secwatch.observer/filing/0001628280-26-038220.md
text_url: https://secwatch.observer/filing/0001628280-26-038220.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/0001628280-26-038220-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/dtil-20260521.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001628280-26-038220

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.